Yanqiong Li Selected Research

Heart Injuries

11/2019

Follistatin-like 1 protects mesenchymal stem cells from hypoxic damage and enhances their therapeutic efficacy in a mouse myocardial infarction model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yanqiong Li Research Topics

Disease

2	Myocardial Infarction 02/2024 - 11/2019
2	Osteoporosis 01/2024 - 11/2023
2	Neoplasms (Cancer) 12/2021 - 01/2013
2	Pulmonary Tuberculosis 12/2014 - 02/2013
1	Pancreatic Neoplasms (Pancreatic Cancer) 12/2021
1	Adenocarcinoma 12/2021
1	Hypoxia (Hypoxemia) 11/2019
1	Cicatrix (Scar) 11/2019
1	Heart Injuries 11/2019
1	Pityriasis Rosea 01/2018
1	Human Influenza (Influenza) 01/2018
1	Ductal Carcinoma 01/2017

Drug/Important Bio-Agent (IBA)

2	FollistatinIBA 02/2024 - 11/2019
2	GlucocorticoidsIBA 01/2024 - 11/2023
2	SeleniumIBA 01/2024 - 11/2023
2	Rifampin (Rifampicin)FDA LinkGeneric 12/2014 - 02/2013
1	EnzymesIBA 12/2021
1	Proteins (Proteins, Gene)FDA Link 12/2021
1	Biomarkers (Surrogate Marker)IBA 12/2021
1	Interferon-alpha (Interferon Alfa)IBA 12/2021
1	VaccinesIBA 01/2018
1	Hepatitis B Vaccines (Hepatitis B Vaccine)IBA 01/2018
1	130-nm albumin-bound paclitaxelIBA 01/2017
1	Capecitabine (Xeloda)FDA Link 01/2017
1	Albumin-Bound Paclitaxel FDA Link 01/2017
1	Therapeutic UsesIBA 12/2014
1	Isoniazid (Ftivazide)FDA LinkGeneric 12/2014
1	AlbuminsIBA 01/2013

Therapy/Procedure

2	Therapeutics 11/2023 - 11/2019
2	Drug Therapy (Chemotherapy) 01/2017 - 02/2013
1	Cell- and Tissue-Based Therapy (Cell Therapy) 11/2019
1	Transplantation 11/2019
1	Modified Radical Mastectomy (Mastectomy, Modified) 01/2017
1	Retreatment 01/2013